CHOP Study: Early Peanut Introduction Slashes Child Allergy Diagnoses

About the study and findings

Researchers at Children’s Hospital of Philadelphia reviewed electronic health records from more than 120,000 children in dozens of pediatric practices to assess trends in allergy diagnoses. The team reported a 27% reduction in peanut allergy diagnoses and a 36–38% decline in new IgE-mediated food allergy diagnoses among children younger than three. The analysis covered diagnoses in the two years after the 2017 National Institute of Allergy and Infectious Diseases guidance on early peanut introduction and was published in Pediatrics on Oct. 20, 2025. For details see the CHOP press release.

Lead author reaction

Stanislaw Gabryszewski, MD, PhD: “We now have data that suggest the effect of this landmark public health intervention is occurring.”

How big are the changes?

Key magnitudes reported in and around the study include:

• Peanut allergy diagnoses: 27% decrease in the study period; some comparisons to earlier baselines report declines up to 43% among very young children since the 2015 LEAP trial results.
• Overall food allergies: A 36–38% reduction in new IgE-mediated food allergy diagnoses; with egg now cited as the most common allergen among young children.

Further reporting and summaries appear in outlets such as the Fox News summary and commentary from the American College of Allergy, Asthma & Immunology (ACAAI).

Why guidance changed: from avoidance to early exposure

For decades parents were advised to avoid peanuts for young children. The 2015 LEAP randomized trial — which showed introducing peanuts between 4 and 11 months in high-risk infants cut peanut allergy risk by about 80% — prompted the 2017 NIAID guidance recommending earlier introduction. By 2021 recommendations expanded to encourage introducing multiple allergenic foods at 4–6 months for most infants. Coverage of parent awareness and confusion is summarized by Lurie Children’s.

Expert reactions and perspective

Allergy specialists called the CHOP findings promising. Cherie Zachary, MD, president of the ACAAI, described the results as “very promising” and evidence the strategy is working. The National Peanut Board highlighted the study as strong real-world proof that early peanut introduction can change public-health outcomes.

Practical guidance for parents

Pediatricians and allergy groups recommend practical, safety-focused steps for families:

• When to introduce: Introduce peanut-containing foods when starting solids, around 4–6 months, especially for infants with eczema or egg allergy.
• Safe forms: Use thinned peanut butter mixed into purees, peanut puffs, or peanut powder mixed into food; never give whole peanuts because of choking risk.
• Maintain exposure: Regular ingestion (about twice a week) during the first year is recommended to promote tolerance; single exposures are unlikely to suffice.
• Consult first: Talk to your pediatrician if your infant has severe eczema, known egg allergy, or other concerns; some infants may need evaluation before introduction.

Practical resources and summaries are available from professional groups like ACAAI and reporting such as the Fox News summary.

Limitations and unanswered questions

The CHOP study is observational rather than randomized, so it demonstrates a strong association but cannot prove causation. Data analyzed end in early 2019, before the broader 2021 guidance to introduce multiple allergens. The study used electronic health records, which may miss undiagnosed cases or lack granular feeding details. Other unmeasured factors could have contributed to the decline. Reporting notes that while diagnoses fell, the study does not directly show how many families followed the guidance or how clinicians advised them; parent awareness research is discussed by Lurie Children’s and clinician-training work by Northwestern University.

Policy and public health implications

Public-health experts say the findings support continued education for parents and clinicians on safe early peanut introduction. If the association reflects a causal effect, early exposure could lower lifetime allergy burden, reduce emergency visits and specialist care, and ease financial and administrative strains for families, schools, and childcare programs.

The CHOP team calls for ongoing monitoring after the 2021 guidance and for studies of long-term outcomes to confirm and extend these initial population-level findings (see the CHOP news release).

Implications for the United States

Economic: Fewer early-childhood diagnoses could reduce short-term medical costs and lower emergency and specialist visits.

Social and cultural: Lower allergy rates can reduce parental anxiety and social exclusion, while fitting within diverse U.S. food traditions when implemented safely.

Practical application: Pediatricians, family doctors, and community clinics should include early peanut guidance in anticipatory counseling; tools and clinician training may improve adherence and sustain gains (JAMA Network research).

Sources and further reading

• CHOP news release on the study
• Fox News summary of the research
• American College of Allergy, Asthma & Immunology reaction
• National Peanut Board statement
• Lurie Children’s findings on parent awareness
• JAMA Network research on parental tools and clinician adherence
• Northwestern University on training tools for pediatricians